Abstract:Abstract Introduction Metabolic impairments and sleep disruptions are both recognized as modifiable risk factors in the development of Alzheimer’s disease (AD). A bidirectional relationship exists between sleep and AD where pathology can disrupt sleep, but sleep disturbances can also increase AD-related pathology. This results in a feed-forward cycle of disease progression and further sleep impairments. Sleep fragmentation and poor sleep quality can also cause glucose intolerance and insulin resistance. However, it remains unclear if peripheral metabolic dysfunction alone can impair sleep, particularly in the context of AD-related pathology. Therefore, the goal of this study was to establish mechanisms connecting peripheral metabolic and sleep disruptions and identify potential therapeutic targets for mitigating AD risk. Methods We implanted biosensors measuring interstitial fluid (ISF) levels of glucose and lactate, biomarkers of cerebral metabolism and neuronal activity, respectively, directly into the hippocampus of wildtype and APP/PS1 mice, a model of amyloid-beta (Aβ) overexpression. Biosensors were paired with cortical EEG and EMG recordings for simultaneous sleep/wake analysis. To understand the relationship between metabolic dysfunction and sleep, we altered the peripheral metabolic environment using two paradigms: an acute high-fat, high-sugar diet (HF/HSD) and a pharmacological metabolic rescue. Results We found short-term HF/HSD exposure was sufficient to disrupt ISF glucose and lactate diurnal rhythms, independent of changes to pathology burden. Moreover, we found significant sleep disruptions, particularly decreased delta power, indicating slow wave sleep impairments. These findings were exacerbated in mice with Aβ pathology who have disrupted metabolic and sleep functioning at baseline. Conversely, we found normalizing peripheral glucose tolerance in mice with Aβ pathology was sufficient to rescue impaired ISF glucose and lactate rhythms. We also saw a restoration of normal sleep-wake patterns, specifically within slow wave activity. Conclusion We found modulating peripheral glucose metabolism can bidirectionally alter sleep, particularly slow wave sleep, independent of changes in Aβ burden. This indicates sleep as a mediator in the relationship between metabolic impairments and AD pathophysiology. While impaired sleep increases AD risk, improved sleep slows pathology accumulation. Therefore, this study demonstrates targeting peripheral glucose regulation is a potential avenue for early AD intervention and risk mitigation. Support (if any) F31-AG066302, R01-AG068330, P30-AG072947

Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden

Does Chronic Sleep Fragmentation Lead to Alzheimer's Disease in Young Wild-Type Mice?

Chronic Sleep Fragmentation Impairs Brain Interstitial Clearance in Young Wildtype Mice.

Interactions between sleep disturbances and Alzheimer's disease on brain function: a preliminary study combining the static and dynamic functional MRI.

P3‐186: THE DEPOLARIZATION AND INTERNALIZATION OF AQUAPORIN‐4 INDUCED BY SLEEP DEPRIVATION COULD INFLUENCE AMYLOID‐BETA CLEARANCE

Glymphatic system health in early Alzheimer's disease and its relationship to sleep, cognition and CSF biomarkers.

Reduced Coupling Between Cerebrospinal Fluid Flow and Global Brain Activity is Linked to Alzheimer Disease–related Pathology

Contribution of Chronic Sleep Deprivation to Age-Related Neurodegeneration in a Mouse Model of Familial Alzheimer’s Disease (5xFAD)

Metabolic and vascular imaging markers for investigating Alzheimer's disease complicated by sleep fragmentation in mice

Sleep and diurnal rest-activity rhythm disturbances in a mouse model of Alzheimer's disease

Aquaporin-4 mis-localization slows glymphatic clearance of α-synuclein and promotes α-synuclein pathology and aggregate propagation

Lateralized brunt of sleep deprivation on white matter injury in a rat model of Alzheimer's disease

Reduced slow-wave activity and autonomic dysfunction during sleep precede cognitive deficits in Alzheimer’s disease transgenic mice

Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model

0085 Peripheral glucose metabolism bidirectionally modulates sleep in a model of Alzheimer's disease

0415 Metabolic Dysfunction and Sleep Disruption in Models of Alzheimer’s Disease

A Chronic Sleep Fragmentation Model Using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

0215 Optogenetic Rescue of Sleep Slows Alzheimer's Progression in a Mouse Model

Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.